BIOMARKERS FOR THE TREATMENT OF MULTIPLE MYELOMA.

摘要

Provided herein are the biomarkers for predicting or monitoring the efficacy of a treatment for multiple myeloma. The use of certain M-protein or other protein levels as biomarkers to predict whether a multiple myeloma treatment is likely to be successful is also provided. Further, the analysis of these biomarkers can be used to monitor progress of treatment effectiveness and patient compliance in multiple myeloma patients who are receiving treatment.